{
  "@context": "https://orbyd.app/schemas/dossier.v1.json",
  "ticker": "CCC",
  "name": "CCC Intelligent Solutions Holdings Inc.",
  "url": "https://orbyd.app/dossiers/CCC/",
  "json_url": "https://orbyd.app/dossiers/CCC.json",
  "status": "DORMANT",
  "current_conviction": "MEDIUM",
  "graded_conviction": "MEDIUM",
  "archetype": {
    "code": "a5",
    "n": 5
  },
  "current_thesis": "Cheap, high-margin insurtech SaaS put in play: a Morgan Stanley-run sale process plus a fresh Elliott activist stake. Shares popped ~13% to ~$6 on the 2026-07-09 Reuters report yet still sit below a plausible PE take-out. The trade is deal-odds, not the claims cycle.",
  "invalidation_trigger": "A daily close below $5.40 fills the 2026-07-10 sale-rumor gap and prices the strategic review failing; a company statement ending or denying the sale process confirms the break.",
  "catalyst_date": "2026-08-14",
  "outcome": "PLAYED_OUT",
  "outcome_date": "2026-08-07",
  "invalidation_fired": false,
  "themes": [
    "m-and-a-special-situations",
    "ai-enterprise-software"
  ],
  "tags": [],
  "sources": [],
  "notes": [
    "Active M&A situation resting on press reports only: no company confirmation of a strategic review as of 2026-08-07.",
    "Management did not address the reported sale process, the review or Elliott on the 2026-07-30 Q2 earnings call.",
    "Balance sheet as stated on the Q2 call: $116M cash, $1.3B total debt, 2.5x net leverage on adjusted EBITDA.",
    "Pre-2026 third-party price history and filings for this issuer often appear under the former symbol CCCS.",
    "Business is US and China P&C insurance workflow software; demand tracks auto collision claims volume, not AI capex."
  ],
  "body_markdown": "## Current Thesis\nThe leg being bought is deal-odds on a take-private, not the P&C claims cycle. Reuters reported on 2026-07-09 that CCC hired Morgan Stanley to run a sale process and had approached private-equity buyers; Bloomberg followed on ~2026-07-14 with Elliott Investment Management building a significant stake, run out of the firm's private-equity arm rather than its activist team, with the position accumulated before the adviser was engaged. Shares closed $5.92 that session. By the 2026-08-07 close the stock was $6.92 — still 31.0% below the $10.03 52-week high, with a 34.9% three-month return and RSI(14) at 67.7.\n\nWhat has changed since the July note: the Q2 print landed on 2026-07-30, ahead of the ~2026-08-05 date previously flagged, and it did not derail anything. Revenue $285.9M (+9.8% YoY) beat the $284.19M consensus, adjusted EBITDA $115.5M versus $108.1M a year earlier, adjusted EPS $0.10 in line, and FY2026 revenue guidance was narrowed upward to $1.158–1.164B. Management did not mention the reported sale process, the strategic review or Elliott on the call. The process has produced no public milestone in the four weeks to 2026-08-07 while the price kept grinding higher — the setup now costs more and carries the same unconfirmed information.\n\n## Bull Case\n- Reuters, 2026-07-09: Morgan Stanley engaged, private-equity buyers contacted — a live auction rather than speculation, and CCC drew takeover interest once before, in 2023.\n- Bloomberg, ~2026-07-14: Elliott's stake is led by its private-equity professionals and was built before the adviser was appointed. Shares closed $5.92 that day, +10%, valuing the equity near $3.5B.\n- Q2 2026 (2026-07-30) confirms the asset quality an LBO needs: software gross dollar retention 98%, net dollar retention 107% (up from 106% for FY2025), free cash flow $82.4M on $101.6M of operating cash flow, GAAP net income $20.8M.\n- FY2026 guidance raised to $1.158–1.164B revenue and $485–491M adjusted EBITDA, a 42% margin at the midpoint — roughly 10% growth at a 40%+ margin is the profile that clears a sponsor model.\n- Balance sheet leaves room: $116M cash against $1.3B total debt, net leverage 2.5x adjusted EBITDA as stated on the Q2 call.\n- Stifel's Buy and $9 target (2026-07-02, pre-rumor) remains the standing upside anchor from the sell side.\n\n## Bear Case\n- Nothing has been confirmed by the company. Two press reports, no 8-K, no announced review, and silence from management on the 2026-07-30 call. Processes of this kind end with no acceptable bid often enough that a 28% premium to the ~$5.40 pre-rumor shelf is already an assumption.\n- Growth is decelerating and the Q3 guide is soft against the Street: $289.5–291.5M (+9%) versus a $291.484M consensus, with adjusted EBITDA guided $118–120M (41% margin) — below the 42% FY margin midpoint.\n- The freshest sell-side mark sits under the tape: Citi kept a Neutral and raised its target only to $6.50 from $6.00 on 2026-08-03, below the 2026-08-07 close of $6.92.\n- Whatever premium a bid carries is now measured from a higher base. A deal struck in the high-$7s or low-$8s would be a modest return from $6.92 while a failed process retraces to the July shelf.\n- 2.5x existing net leverage plus a ~$3.8B equity value means any sponsor needs a sizeable financing package; leveraged-finance conditions are an exogenous variable this thesis cannot control.\n\n## Setup & Price Structure\n- Life-cycle: **MATURING**. The accelerating phase ran 2026-07-09 to ~2026-07-14 (Reuters, then Bloomberg/Elliott). Since 2026-07-14 there has been no new process headline; the 2026-07-30 print came and went without management addressing it; the only fresh analyst action, Citi on 2026-08-03, marked to $6.50 — under the market. Well known, still working, thinner new information.\n- Reference levels: ~$5.40 implied pre-rumor shelf (from the 2026-07-10 +13.01% move to ~$6.09 after hours); $5.92 close on the 2026-07-14 Elliott session; $6.46 close on 2026-08-05; $6.92 close on 2026-08-07 with no dated company news in between. The operative floor has migrated up from the July note's $5.40 to the $5.90 zone.\n- Overhead: $10.03 is the 52-week high, 31.0% above the 2026-08-07 close; Stifel's $9 (2026-07-02) sits inside that.\n- Crowding observables, stated as observed: RSI(14) 67.7 at the 2026-08-07 close; +34.9% over three months; the shares traded through the most recent published price target within two sessions of it being raised; retail-facing coverage in July clustered on the \"moving higher\" premarket-gainer format (Benzinga, 2026-07-10) rather than on the fundamentals. No Section 16 insider transactions appeared in the filing record reviewed through 2026-08-07. No earnings date falls inside the next 30 days, so there is no scheduled print to compress positioning into.\n\n## Catalyst Calendar (next 30 days)\n- **2026-08-14** — 13F deadline for positions held at 2026-06-30. Whether Elliott's stake appears, and at what reported size, is checkable that day. A stake built via swaps or options, or accumulated after 2026-06-30, would not show.\n- **Undated, dominant** — any process milestone: identification of bidders, a confirmed strategic review, an indicative bid, an Elliott 13D/13D/A, or a report that talks have collapsed. Nothing on this list has a scheduled date, which is the structural weakness of the window.\n- **~2026-11-03 (est.)** — Q3 2026 print, outside the 30-day window. Guided to $289.5–291.5M revenue and $118–120M adjusted EBITDA on 2026-07-30.\n\n## What Would Change Our Mind\nThe structure that matters is the $5.90 shelf built on the 2026-07-14 Elliott session; losing it erases the second of the two headlines the entire re-rate rests on and leaves an unconfirmed July rumor holding a 28% premium. A weekly close below $5.90 is the gradeable break. Two secondary conditions carry equal weight: a company statement, credible report or proxy disclosure that the review concluded without a transaction; and the 2026-08-14 13F passing with no Elliott position disclosed and no follow-up filing, which would leave the stake resting entirely on a single Bloomberg report. On the other side, a confirmed strategic review or a named bidder would reset this as an event with a definable spread instead of a rumor with a wide one. A fundamental break would look like the FY2026 revenue guide being cut back below $1.158B at the Q3 print, or net dollar retention slipping under the 107% posted for Q2.\n\n## Correlation Notes\n- While the process is live, the name trades on deal-odds and decouples from the software tape; if the review dies it re-couples to SaaS multiples on a business guiding ~9–10% growth, which is where the pre-rumor $5.40 came from.\n- The AI framing on this name is insurance-workflow AI sold to carriers and roughly 30k repair facilities. Demand is tied to US auto collision claims volume and carrier cost discipline, not to hyperscaler capex, so it is a poor read-through from the AI-infrastructure complex in either direction.\n- Sensitivity runs through leveraged finance: sponsor bids for a ~$3.8B equity value on top of $1.3B of existing debt price off high-yield and leveraged-loan conditions. Spread widening is a headwind to the deal leg independent of anything CCC reports.\n- Read-throughs come from other insurance/vertical-software take-privates and from Elliott private-equity-arm situations, not from the P&C carriers themselves.\n- Data hygiene: pre-2026 third-party price history and filings for this issuer frequently appear under the former symbol CCCS. Verify the symbol before pulling a long history.",
  "first_seen": "2026-07-15",
  "last_analyzed": "2026-08-09T19:35:05+00:00",
  "last_synthesized": "2026-08-09",
  "last_update_source": "watchlist_research",
  "license": "Content © orbyd. Cite the canonical URL."
}